Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (92)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MCCARTHY, S. T.
Right arrow Articles by TURNER, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MCCARTHY, S. T.
Right arrow Articles by TURNER, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 Oxford University Press

research-article

LOW-DOSE SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS AND PULMONARY EMBOLI FOLLOWING ACUTE STROKE

S. T. MCCARTHY, Consultant Physician and J. TURNER, Consultant Physician

Radcliffe Infirmary Woodstock Road, Oxford OX2 6HE
Walton Hospital, Liverpool

Venous thrombo-embolism is a major and often unrecognized cause of morbidity and mortality in patients after acute strokes.

Three hundred and five elderly patients were randomly allocated to either control (161) or treatment (144) with 5000 units calcium heparin subcutaneously 8-hourly for two weeks. A reduction in deep-vein thrombosis rate from 72.7% in the control group to 22.2% in treatment patients was achieved. In patients who died (84), post-mortem examination to look for pulmonary emboli was performed in 71. Comparison between treated and untreated patients showed significantly fewer deaths and pulmonary emboli in the treated group. Most of the beneficial effect on mortality was seen in patients with lighter strokes. When patients with pulmonary emboli at post-mortem were excluded, there was no significant difference in the death rate in treatment (17) and control (14) groups. At post-mortem, 9.9% of the strokes were haemorrhagic (4 in the treatment and 3 in the control group).

Low-dose calcium heparin given subcutaneously following acute stroke reduced the number of deep-vein thromboses, pulmonary emboli and deaths without increasing the number of haemorrhagic strokes in this study.

accepted in revised form August 6, 1985.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
L. Wein, S. Wein, S. J. Haas, J. Shaw, and H. Krum
Pharmacological Venous Thromboembolism Prophylaxis in Hospitalized Medical Patients: A Meta-analysis of Randomized Controlled Trials
Arch Intern Med, July 23, 2007; 167(14): 1476 - 1486.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Circulation, May 22, 2007; 115(20): e478 - e534.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
Stroke, May 1, 2007; 38(5): 1655 - 1711.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Paciaroni, G. Agnelli, S. Micheli, and V. Caso
Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials
Stroke, February 1, 2007; 38(2): 423 - 430.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H.-C. Diener, E. B. Ringelstein, R. von Kummer, H. Landgraf, K. Koppenhagen, J. Harenberg, I. Rektor, A. Csanyi, D. Schneider, J. Klingelhofer, et al.
Prophylaxis of Thrombotic and Embolic Events in Acute Ischemic Stroke With the Low-Molecular-Weight Heparin Certoparin: Results of the PROTECT Trial
Stroke, January 1, 2006; 37(1): 139 - 144.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. C. Spyropoulos
Emerging Strategies in the Prevention of Venous Thromboembolism in Hospitalized Medical Patients
Chest, August 1, 2005; 128(2): 958 - 969.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
W. S. Aronow
The Prevention of Venous Thromboembolism in Older Adults: Guidelines
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2004; 59(1): M42 - 47.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. P. Adams Jr, R. J. Adams, T. Brott, G. J. del Zoppo, A. Furlan, L. B. Goldstein, R. L. Grubb, R. Higashida, C. Kidwell, T. G. Kwiatkowski, et al.
Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association
Stroke, April 1, 2003; 34(4): 1056 - 1083.
[Full Text] [PDF]


Home page
NeurologyHome page
B. M. Coull, L. S. Williams, L. B. Goldstein, J. F. Meschia, D. Heitzman, S. Chaturvedi, K. C. Johnston, S. Starkman, L. B. Morgenstern, J. L. Wilterdink, et al.
Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)
Neurology, July 9, 2002; 59(1): 13 - 22.
[Full Text] [PDF]


Home page
StrokeHome page
B.M. Coull, L.S. Williams, L.B. Goldstein, J.F. Meschia, D. Heitzman, S. Chaturvedi, K.C. Johnston, S. Starkman, L.B. Morgenstern, J.L. Wilterdink, et al.
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)
Stroke, July 1, 2002; 33(7): 1934 - 1942.
[Full Text] [PDF]


Home page
ChestHome page
D. M. Arnold, S. R. Kahn, and I. Shrier
Missed Opportunities for Prevention of Venous Thromboembolism : An Evaluation of the Use of Thromboprophylaxis Guidelines
Chest, December 1, 2001; 120(6): 1964 - 1971.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Kelly, A. Rudd, R. Lewis, and B. J. Hunt
Venous Thromboembolism After Acute Stroke
Stroke, January 1, 2001; 32(1): 262 - 267.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. H. Geerts, J. A. Heit, G. P. Clagett, G. F. Pineo, C. W. Colwell, F. A. Anderson Jr., and H. B. Wheeler
Prevention of Venous Thromboembolism
Chest, January 1, 2001; 119(1_suppl): 132S - 175S.
[Full Text] [PDF]


Home page
StrokeHome page
R. L. Harvey, E. J. Roth, P. R. Yarnold, J. R. Durham, and D. Green
Deep Vein Thrombosis in Stroke: The Use of Plasma D-Dimer Level as a Screening Test in the Rehabilitation Setting
Stroke, September 1, 1996; 27(9): 1516 - 1520.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.